Article Text

Survey of Ehrlichia canis antibodies among dogs in Israel
  1. G. Baneth, DVM1,
  2. T. Waner, BVSc, MSc2,
  3. A. Koplah, DVM1,
  4. S. Weinstein, DVM1 and
  5. A. Keysary, PhD3
  1. 1 Koret School of Veterinary Medicine, Hebrew University of Jerusalem, PO Box 12, Rehovot, 76100 Israel
  2. 2 Life Science Research Israel, PO Box 139, Ness Ziona, 70451 Israel
  3. 3 Israel Institute for Biological Research, PO Box 19, Ness Ziona, Israel


A seroepidemiological survey was made of the prevalence of antibodies reactive with Ehrlichia canis in stray and pet dogs from five geographical regions of Israel. Serum samples from 410 dogs were assayed by an indirect fluorescent antibody test and serum reactive at a 1:20 dilution or greater was considered positive. The overall seroprevalence was 30 per cent with 23.9 per cent in pet dogs and 37.5 per cent in stray dogs. The seroprevalence in apparently healthy pets (17.6 per cent) was lower but did not differ significantly from the seroprevalence in sick animals (26.6 per cent). The seroprevalence was highest in the north of Israel and lowest in the central hilly area, and followed the same trend in both the populations sampled. Young dogs (under one year old) had a lower seroprevalence (14.9 per cent) than adult (one to eight years) (36.4 per cent) or older dogs (over eight years) (34.2 per cent). The results demonstrate that dogs in Israel are extensively exposed to E canis and indicate that ehrlichiosis is endemic in this area of the Middle East.

Statistics from

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.